Magnesio Solfato Galenica Senese

Magnesium sulfate, the active ingredient in Magnesio Solfato, is an electrolyte presented as an injectable solution for intramuscular and intravenous use. It is employed to correct magnesium deficiency and to manage conditions such as eclampsia, ventricular arrhythmias, severe asthma exacerbations, and as an adjunct in cardiac arrest.

GNH USA supplies Magnesio Solfato as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company follows stringent quality standards and provides regulatory documentation for across global distribution.

Magnesium sulfate is used to replenish extracellular magnesium and to treat conditions related to electrolyte imbalance.

Magnesium deficiency: restores normal serum magnesium levels. Eclampsia/preeclampsia: prevents and treats seizures in pregnant patients. Ventricular arrhythmias: stabilises cardiac rhythm in torsades de pointes and other life‑threatening arrhythmias. Severe asthma exacerbations: relaxes bronchial smooth muscle to improve airflow. Cardiac arrest adjunct: supports myocardial function and reduces refractory ventricular fibrillation.

Adverse reactions may occur with magnesium sulfate administration.

Common Side Effects: - Flushing or feeling of warmth. - Sweating. - Nausea or vomiting. - Mild hypotension. - Headache. - Local irritation at injection site.

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse. - Respiratory depression or arrest. - Hypermagnesemia leading to cardiac arrhythmias. - Neuromuscular blockade. - Anaphylactic reaction. - Tissue necrosis if extravasation occurs.

Magnesium sulfate requires careful monitoring in several clinical situations.

Renal impairment: monitor serum magnesium and adjust dose. Cardiac disease: use cautiously due to potential hypotension. Neuromuscular disorders: observe for enhanced blockade. Pregnancy: risk unknown; weigh benefits against potential fetal effects. Drug compatibility: avoid mixing with calcium‑containing solutions. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Calcium gluconate or calcium chloride: may precipitate and cause embolism. - Neuromuscular blocking agents: can potentiate blockade leading to respiratory failure. - Aminoglycoside antibiotics: increased risk of neuromuscular weakness.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may raise serum magnesium levels. - Digoxin: risk of toxicity with hypermagnesemia. - Quinolone antibiotics: may affect magnesium absorption and reduce efficacy.